– Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo's CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 (liafensine) in treatment-resistant depression (TRD) – SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) — Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced the […]

(CNSX:HG.CN),(OTC US:HGRAF),(Other OTC:HGRAF),(Frankfurt:M98), VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: ‎HG) (OTCQB: HGRAF) (the “Company” or “HydroGraph“) a leading producer of ultra-pure graphene and advanced nanomaterials, today announced the appointment of two new independent directors to its Board. President & CEO Kjirstin Breure stated: “I am pleased to

(NASDAQ:ARVN),(NYSE:PFE), – This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine – – VERITAC-2 data support vepdegestrant as a potential treatment option in patients with ESR1m ER+/HER2-

(TSX:FURY),(NYSE MKT:FURY), NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 06, 2025 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company“) announces that the proposed private placement offering announced June 5, 2025 has been increased from C$2,500,000 to C$3,080,000.

(NASDAQ:BCRX), RESEARCH TRIANGLE PARK, N.C., June 06, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that, following a positive recommendation from the Zorginstituut Nederland, ORLADEYO(R) (berotralstat) has been approved for the routine prevention of hereditary angioedema (HAE) attacks in patients aged 12 years and older. This reimbursement approval in the Netherlands marks

(NASDAQ:GIII), Net Income Per Diluted Share of $0.17 for the First Quarter Compared to $0.12 Last Year and Non-GAAP Net Income Per Diluted Share of $0.19 for the First Quarter Compared to $0.12 Last Year, Both Exceeding Guidance Net Sales of $583.6 Million for the First Quarter Compared to $609.7 Million Last Year Repurchases of

(Other OTC:OTCM),(OTC US:OTCM),(TSX:NEO),(OTCQX:NOPMF), NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Neo Performance Materials Inc (TSX: NEO; OTCQX: NOPMF), a manufacturer of the building blocks of many modern technologies that enhance efficiency and sustainability, has qualified

QUEBEC CITY, June 06, 2025 (GLOBE NEWSWIRE) — Families, friends, and community members will gather today at MADD Canada's Quebec Provincial Memorial in Quebec City to remember and honour the innocent lives lost in crashes involving alcohol, cannabis and/or other drugs. This year, the names of two more victims have been added to the Memorial,

(Helsinki:NOKIA),(Irish:IRSH),(LSE:0HAF),(Paris:NOKIA), Nokia CorporationStock Exchange Release6 June 2025 at 14:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 129 878 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's equity-based incentive plans in accordance with the rules of the plans. The transfer is based

Miami, USA, June 06, 2025 (GLOBE NEWSWIRE) — Bitline, the industry's sole provider enabling direct access to land-based casino chips from cryptocurrency and digital asset holdings in a physical casino environment, is partnering with TRM Labs, a leading provider of blockchain intelligence and transaction monitoring services. The partnership involves merging TRM Labs' forensic monitoring capabilities